Welcome, Guest
You have to register before you can post on our site.

Username
  

Password
  





Search Forums

(Advanced Search)

Forum Statistics
» Members: 2,796
» Latest member: dodgew1tch
» Forum threads: 7,059
» Forum posts: 123,416

Full Statistics

Latest Threads
Odds and Ends ... With So...
Forum: The Lounge
Last Post: IceWizard
11-13-2026, 01:20 AM
» Replies: 11
» Views: 3,083
Here are a couple I found
Forum: IOPList Suggested IOP's
Last Post: gujjernoran
11-12-2026, 08:26 PM
» Replies: 1
» Views: 798
www.MacroMass.COM.PH
Forum: IOPList (Approved & Recommended)
Last Post: Macro Mass
11-11-2026, 04:56 PM
» Replies: 3,854
» Views: 7,143,967
The Juke Box is OPEN
Forum: The Lounge
Last Post: Mr. HIND
11-09-2026, 08:03 AM
» Replies: 2,939
» Views: 1,665,599
MOVIES
Forum: The Lounge
Last Post: IceWizard
11-09-2026, 05:10 AM
» Replies: 147
» Views: 49,572
www.MacroMass.COM.PH
Forum: IOP Discounts, Offers & More
Last Post: Macro Mass
11-08-2026, 09:07 PM
» Replies: 143
» Views: 81,174
Humorous Smilies
Forum: The Lounge
Last Post: IceWizard
11-02-2026, 01:22 AM
» Replies: 4,936
» Views: 4,271,614
Deaths So Far (and it's j...
Forum: World News
Last Post: IceWizard
10-31-2026, 07:15 PM
» Replies: 51
» Views: 14,564
'Biscuit' the dog is late...
Forum: World News
Last Post: IceWizard
10-31-2026, 06:16 PM
» Replies: 0
» Views: 164
GAME - Change one word ga...
Forum: The Lounge
Last Post: IceWizard
10-15-2026, 05:21 AM
» Replies: 2,142
» Views: 1,021,018

 
Star 5 Things You Should Know About Social Security
Posted by: IceWizard - 08-10-2015, 01:22 PM - Forum: World News - No Replies

Social Security isn’t just for retirees, and provides valuable insurance to workers of all ages.

By Emily Brandon Aug. 10, 2015 | 9:00 a.m. EDT

Social Security was initially a program that provided payments to retired workers when
President Franklin D. Roosevelt signed the bill
on August 14, 1935. But the 80-year-old program has since been amended to include payments for the spouses and dependent children of workers who prematurely pass away and disability benefits for those who become unable to work.

Here are some of the important features of the Social Security program.

How much you are paying in.
Most workers contribute 6.2 percent of their paychecks to the Social Security system, and employers match that amount. Self-employed workers pay 12.4 percent of their income into the system. The Social Security tax applies to earnings of up to $118,500 in 2015. Earnings above this amount are not subject to Social Security tax or factored into retirement payments.

The age to sign up.
You can sign up for retirement benefits beginning at age 62, but payments are reduced if you sign up before your full retirement age, which is 66 for most baby boomers and 67 for everyone born in 1960 or later. Your monthly payments will increase if you delay signing up past your full retirement age. However, after age 70 there is no additional boost in payments if you wait to claim Social Security. "Assuming you have normal health, try to claim Social Security as close to 70 as you can," says Alicia Munnell, director of the Center for Retirement Research at Boston College.

How much you will receive.
Social Security payments are calculated using the 35 years in which you earn the most. If you don't work for 35 years, zeros are factored into the calculation. You can get a personalized estimate of your future Social Security payments at various claiming ages by creating a My Social Security account online at ssa.gov/myaccount and logging in to view your Social Security statement. These statements also list your earnings history and taxes paid, which you can check for errors. Paper Social Security statements are mailed to most workers who don't have My Social Security accounts about once every five years.

What happens if you become disabled. "We started off with just a retirement program, and then in 1939 we added survivors benefits and in 1956 we expanded to include people with disabilities," says Carolyn Colvin, Acting
Commissioner of the Social Security
Administration. If you develop a physical or mental impairment that is expected to prevent
you from working for a year or more, you may
qualify for disability payments. Your Social Security statement will list an estimate of your monthly payments if you become disabled. You may need to provide documentation about your condition and why it will prevent you from working.

How much your family will get if you pass
away
.
Social Security also functions as life insurance for workers who prematurely pass away. Children ages 19 and younger who are in
school, disabled children and a spouse caring
for children younger than age 16 will each be
eligible for monthly payments from Social Security, which are subject to a maximum amount the entire family qualifies for. Your Social Security statement will list how much your family members are likely to receive if you die. "Social Security is designed to insure against lost wages," says Eric Kingson, a professor of social work at Syracuse University. "The premium that we pay is designed to insure against risk."

Print this item

  Novavax hopes to crack elusive vaccine for common respiratory virus
Posted by: IceWizard - 08-10-2015, 12:58 PM - Forum: World News - No Replies

Mon Aug 10, 2015 1:01am EDT
By Natalie Grover

[bb](Reuters)[/b] -
A Maryland-based biotech company believes it can solve a riddle that has baffled Big Pharma for decades: how to protect against a virus that infects almost every American child.

If mid-stage trial data proves positive, Novavax
Inc will be closer than any drug developer to a
vaccine for respiratory syncytial virus, or RSV,
which affects those most with compromised
immune systems - including young infants and
the elderly.

An effective vaccine would represent a $1 billion opportunity in the United States and potentially double that worldwide, said Heather Behanna, an analyst at Wedbush Securities.
But the complex molecular structure of the virus has proven to be an issue for drug developers in the nearly 60 years since its discovery.

If the mid-stage trial data disappoints, Novavax will join a handful of other developers that have failed at this stage. Most children in the United States will suffer an RSV infection before their second birthday, according to the Centers for Disease Control and Prevention.

For most older healthy children and adults, it
causes little more than a common cold, but in
high-risk groups it can lead to more serious lung and airway infections.

It is the leading cause of bronchiolitis, an
inflammation of the small airways, as well as
pneumonia in children less than a year old.

On average, RSV kills fewer people than
influenza - between 10,000 and 15,000 elderly
Americans a year, compared with 20,000 to
50,000 older adults for flu deaths, according to
researcher Dr. Pedro Piedra of the Baylor
College of Medicine, who also serves on Novavax's scientific advisory board.

However, RSV is the major viral pathogen in
infants, killing about 500 infants every year in
the United States, Piedra said. RSV is also responsible for more than 2 million
outpatient visits a year by children under the
age of five - a huge drain on the country's
healthcare resources.

Novavax estimates hospital costs associated with RSV in older adults alone costs the U.S. healthcare system about $23 billion.

With so many cases, Chief Executive Stanley
Erck says Novavax's drug has the potential to
be "the largest selling vaccine in the history of
vaccines in terms of revenue".

It could be ready as early as 2017, he told Reuters. Novavax's mid-stage data in the elderly, expected this quarter, aims to prove that the vaccine can prevent RSV infection in this population.

Meanwhile, the company is also immunizing mothers in a separate mid-stage trial in an attempt to jumpstart infant immunity. Data from this study is expected in the third quarter.

SEASONAL VIRUS, BUT NOT THE FLU


In the mid-1960s, developers followed the same strategy that had worked with influenza: they grew the virus in a lab, killed it and used the dead cells to develop a vaccine.

Like the flu, RSV is a seasonal virus. But it
proved far different than the flu.

Those exposed in early testing fell sick; a trial in 1966 resulted in the deaths of two toddlers.

(http://bit.ly/1h32MRW)

That episode halted trials for many years, said Dr. Leonard Krilov, Chief of Pediatric Infectious Diseases at Winthrop-University Hospital in Mineola, New York.

As researchers developed a better molecular understanding of RSV, testing resumed.

Several big companies, including Novartis AG,
GlaxoSmithKline Plc and Bavarian Nordic A/S,
are also conducting clinical trials but Behanna of Wedbush expects Novavax to reach later stages of development earlier.

MedImmune, now part of AstraZeneca Plc,
developed a drug, Synagis, that can prevent
lung infections caused by RSV. It has been used to treat more than 2 million babies worldwide since 1998, but it cannot prevent the RSV infection itself.

It is also expensive. The average seasonal cost per patient during the 2013-2014 RSV season was about $6,400, AstraZeneca said.

Behanna estimated the Novavax vaccine might have a retail cost about $40 a shot for the elderly and $100 for pregnant American women.

Erck said Novavax was considering tiered global pricing for its vaccine but that it was too early to provide details.

The mid-stage data could allow Novavax to
determine dosage strength for the elderly and
to help design a late-stage trial planned for this RSV season, which corresponds roughly with winter.


(Reporting by Natalie Grover in Bengaluru;
Editing by Robin Paxton and Bernard Orr)

Print this item

  Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills
Posted by: IceWizard - 08-10-2015, 12:51 PM - Forum: World News - No Replies

Mon Aug 10, 2015 1:03am EDT

PARIS (Reuters) -
Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to develop a new type of immune system-boosting cancer medicine that could be given as tablets to fight both solid tumors and blood cancers.

The French drugmaker said on Monday the tie
up would focus on developing small molecule-
based immuno-oncology treatments, which could complement currently available inhibitors.
Under the collaboration, Sanofi has the option of screening its own compound libraries to identify new small-molecule candidates for development, it said in a statement.

The group will support two years of research
funding for Evotec and Apeiron and pay Evotec potentially more than 200 million euros ($219 million) if promising molecules are identified.

The French group said it would have sole
responsibility for all development, regulatory,
commercial and manufacturing activities of the
products.

Last week, Sanofi announced a partnership with Evotec to develop stem cell-based treatments for diabetes. The company is also working closely with its long-time partner Regeneron Pharmaceuticals in the area of cancer immunotherapy.


(Reporting by Matthias Blamont; Editing by
Geert De Clercq and Mark Potter)

Print this item

  AstraZeneca bags another cancer drug deal, this time with Inovio
Posted by: IceWizard - 08-10-2015, 12:47 PM - Forum: World News - No Replies

Mon Aug 10, 2015 4:24am EDT

LONDON (Reuters) -
AstraZeneca has clinched its third deal in less than a week to bolster its strategically important cancer drug pipeline by signing up rights to an experimental immune system-boosting medicine from Inovio
Pharmaceuticals.

Inovio will get $27.5 million upfront and potential future payments of up to $700 million, depending on the success of its INO-3112 immunotherapy, which targets cancers caused by human papillomavirus (HPV) types 16 and 18.

AstraZeneca said on Monday its MedImmune
biotech unit would study INO-3112 in combination with other immunotherapy drugs. INO-3112, which is in Phase I/II clinical trials for cervical and head and neck cancers, works by generating killer T-cell responses that are able to destroy HPV 16- and 18-driven tumors.
The two HPV types are responsible for more than 70 percent of cervical cancer. The deal follows other recent immuno-oncology
tie-ups by AstraZeneca with Sosei subsidiary
Heptares and Mirati.


(Reporting by Ben Hirschler; Editing by Susan
Fenton)

Print this item

  Back to the future: Nokia prepares for mobile comeback
Posted by: IceWizard - 08-10-2015, 12:36 PM - Forum: World News - No Replies

Mon Aug 10, 2015 2:05am EDT
By Eric Auchard, Jussi Rosendahl and Leila
Abboud

FRANKFURT/HELSINKI (Reuters) - Nokia NOK1V.HE is hiring software experts, testing new products and seeking sales partners as it plots its return to the mobile phone and consumer tech arena it abandoned with the sale of its handset business.
Once the world's biggest maker of mobile
phones, the Finnish firm was wrongfooted by the rise of smartphones and eclipsed by Apple (AAPL.O) and Samsung (005930.KS).

It sold its handset business to Microsoft (MSFT.O) in late 2013 and has since focused squarely on making telecoms network equipment.

Now Nokia boss Rajeev Suri is planning a
comeback. He must wait until late 2016 before he can consider re-entering the handset business - after a non-compete deal with Microsoft expires - but preparations are underway.

The company has already dipped its toe into the consumer market; it has launched an Android tablet, the N1, which went on sale in January in China and days ago unveiled a "virtual-reality camera" - heralding it as the "rebirth of Nokia".

It has also launched an Android app called Z
Launcher, which organizes content on
smartphones.

Meanwhile its technologies division has
advertised on LinkedIn dozens of jobs in
California, many in product development,
including Android engineers specializing in the
operating software Nokia mobile devices will
use.

Nokia had also planned to lay off about 70
people at the division, according to a May
announcement, but a company source told
Reuters that the figure had since been halved.

PATENT TROVE

Nokia itself is not giving much away about its
preparations, beyond saying some staff at the
600-strong technologies division are working on designs for new consumer products, including phones, as well as in digital video and health.

But it will not be easy to claw its way back to
relevance in the fast-changing, competitive
mobile business where Apple (AAPL.O) has been scooping up nearly 90 percent of industry profits, nor for it to carve out a place in electronics.

One ace Nokia that holds is ownership of one of the mobile industry's biggest troves of
intellectual property, including patents it retained after selling its handset business. It does not want to waste such resources, built up with tens of billions of euros of investment over the past two decades.

It will also get an injection of talent when it
completes the 15.6-billion-euro ($17 billion)
acquisition of Alcatel-Lucent, announced in April, in the form of Bell Labs - a U.S. research center whose scientists have won eight Nobel prizes.


It says it will not repeat the mistakes of the past of missing technology trends, being saddled with high costs, and reacting too slowly to changing consumer tastes.

To blunt such risks, it is seeking partners for
"brand-licensing" deals whereby Nokia will
design new phones, bearing its brand, but - in
exchange for royalties - will then allow other
firms to mass-manufacture, market and sell the
devices.

This is stark contrast to its previous handset
business which in its heyday manufactured more phones than any other company in the world and employed tens of thousands.

Suri said last month that Nokia aimed to re-enter the mobile phone business, but only through such licensing agreements. It will not fall back on the "traditional" methods, said the CEO, who took the helm last May and has turned it into a slimmed down, more profitable company. He sold off its mapping business a week ago.

Such brand-licensing deals - as Nokia has struck for the N1 tablet - are less profitable than manufacturing and selling its own products, but also less risky.

They can add a tidy sum of revenue for little investment for the company, which generates the bulk of income from selling telecoms network equipment to operators like
Vodafone and T-Mobile.

"They want to be innovative and seen as a
company with long-term vision in the (tech)
industry and having a foot in devices plays into
this impression, even if it's not bringing massive revenue at the outset," said Gartner analyst Sylvain Fabre.

NEWCOMERS

Brand-licensing models are not new in the
industry; European companies like Philips
(PHG.AS) and Alcatel have made money from consumer electronics by licensing out their
brand after capitulating to Asian competitors
more than a decade ago.

But given the crop of newcomers like China's
Xiaomi and India's Micromax, it may not be
possible for Nokia to reproduce even the minor
successes that Philips and Alcatel were able to
achieve by renting out their brand.

With advances in contract manufacturing and
standardization of software, components and
features like touch-screens, it is also easier than ever for companies to outsource everything to produce lookalike phones.

"We only see this competitive pressure
intensifying in coming years," said CCS Insight
mobile analyst Ben Wood. "Barriers to entry in
the handset market are lower than ever and
almost anyone can enter the smartphone
market.

The strength of the Nokia brand - crucial to the
success of such licensing deals - is also open to debate. The company says its brand is recognized by four billion people. But, after being consistently ranked as one of the world's top-five brands in the decade up to 2009 according to market researcher Interbrand, it has since nose-dived
and now looks set to disappear from top 100 lists.

"A brand is quickly forgotten if it is absent from
the consumer business," said former Nokia
executive Anssi Vanjoki, a professor at Finland's Lappeenranta University of Technology.

"The brand will not help much if the product is
similar to what is already being sold out there.
But if there is something new and interesting to it, the old heritage may be helpful."


(Editing by Pravin Char)

Print this item

  Alibaba to invest $4.6 billion in China electronics retailer Suning
Posted by: IceWizard - 08-10-2015, 12:24 PM - Forum: World News - No Replies

Mon Aug 10, 2015 7:45am EDT
By Gerry Shih

BEIJING (Reuters) -
Alibaba Group Holding Ltd will invest $4.6 billion in leading Chinese electronics retailer Suning Commerce Group Co Ltd, its biggest step yet towards integrating online and store-based shopping.

Alibaba is paying 28.3 billion yuan ($4.56 billion) for newly issued Suning shares and will
ultimately hold a 19.99 percent stake. Suning will in turn invest 14 billion yuan to acquire 1.1
percent of Alibaba through the purchase of new shares, the two said in a joint statement.

The deal comes when Chinese companies, as
well as the country's top policymakers, have
espoused combining offline and online sectors
as a lucrative new business model.

Baidu Inc, China's dominant Internet search
provider, has said it would invest $3.2 billion
over the next three years in such services, while property conglomerate Dalian Wanda Group said last month its entertainment arm would lead a $1 billion investment in a travel website.

Alibaba's latest alliance would, in practical terms, allow its online customers to go into one of Suning's 1,600 outlets in China to try out a product before purchasing it on Alibaba's
website using their smartphone.

Suning, which has long boasted a formidable
logistics operation, would join forces with
Alibaba's distribution network to deliver goods in as little as two hours, the companies said.

INTERNET STRATEGY

China's leaders have been fleshing out a broad Internet sector strategy known as "Internet Plus" to combine online and offline industries and encourage more technology-driven, high-value economic output as the world's second-largest economy wrestles with slowing growth.

For Alibaba, the alliance could reinforce its
position against its main e-commerce rival
JD.com, which has traditionally enjoyed healthy sales of electronics and gadgets. Alibaba will open a new section dedicated to Suning on its popular TMall shopping website.
Alibaba has been seeking to strengthen its
electronics offerings in recent years, inking tie-
ups with Gome Electrical Appliances Holding Ltd and Haier Electronics Group Co Ltd to offer home appliances online.

Speaking to reporters on Monday, Alibaba Chief Executive Daniel Zhang said he would consider striking more deals with brick-and-mortar stores beyond electronics, as long as those retail chains "can bring us additional customers."

But he maintained that Alibaba's interest in
Suning did not reflect any fundamental shift in
Alibaba's strategy toward becoming more of a
physical retailer itself.


"We are trying to build an integrated online-
offline platform for both customers and
merchants," Zhang said. "We don't change our
strategy. We're still a platform company."

Alibaba's Tmall faced challenges holding onto its long-held dominance in Chinese e-commerce, said James Roy, associate principal from China Market Research Group in Shanghai.

"From Alibaba's point of view, acquiring or
having such a strategic alliance with a fairly
large competitor will help them to continue to
enjoy that strong position."

JD.com played down its rival's new partnership.

"Over 12 years we've built a reputation for
amazing delivery speed and attention to
customer experience. That's why we've been
able to build a market leading position, and it's
very tough to duplicate," JD.com said in a
statement

($1 = 6.2096 Chinese yuan renminbi)


(Reporting by Gerry Shih; Additional reporting
by Danny Kwok; Editing by Edmund Klamann
and Keith Weir)

"We are trying to build an integrated online-
offline platform for both customers and
merchants," Zhang said. "We don't change our
strategy. We're still a platform company."

Alibaba's Tmall faced challenges holding onto its long-held dominance in Chinese e-commerce, said James Roy, associate principal from China Market Research Group in Shanghai.

"From Alibaba's point of view, acquiring or
having such a strategic alliance with a fairly
large competitor will help them to continue to
enjoy that strong position."

JD.com played down its rival's new partnership.

"Over 12 years we've built a reputation for
amazing delivery speed and attention to
customer experience. That's why we've been
able to build a market leading position, and it's
very tough to duplicate," JD.com said in a
statement

($1 = 6.2096 Chinese yuan renminbi)


(Reporting by Gerry Shih; Additional reporting
by Danny Kwok; Editing by Edmund Klamann
and Keith Weir)

Print this item

  Anyone ever heard of or used lifesaver med dot com
Posted by: Rumor - 08-10-2015, 06:05 AM - Forum: Random Suggest IOP's - Replies (1)

They have lots of hard to finds at reasonable prices and take cc. I am sure they are too good to be true, but it never hurts to ask. Thank you. R.

Print this item

  MSJ Valium?
Posted by: Rumor - 08-09-2015, 06:18 PM - Forum: Who's Got It - Replies (15)

Anyone have a source for the real ones? Thank you! R.

Print this item

  Robert J. Bentley, Gov of Alabama, Says Cutting Medicaid Payment_Planned Parenthood
Posted by: IceWizard - 08-09-2015, 02:56 PM - Forum: World News - No Replies

In wake of scandal surrounding videos, Alabama governor says the state will stop funding the group.

Associated Press Aug. 7, 2015
7:56 a.m. EDT

KIM CHANDLER, Associated Press

MONTGOMERY, Ala. (AP) —
Alabama Gov. Robert Bentley said Thursday that he is cutting off state Medicaid payments to Planned Parenthood in the face of undercover videos shot by anti-abortion activists that implied the group was selling fetal tissue to researchers.

The Republican governor sent Planned
Parenthood Southeast a letter announcing that
he was terminating agreements that allowed
Planned Parenthood to be reimbursed for
providing health care services to Medicaid
patients. Louisiana Gov. Bobby Jindal, who is running for GOP presidential nomination,
announced a similar decision Monday.

"The deplorable practices at Planned
Parenthood have been exposed to Americans,
and I have decided to stop any association with the organization in Alabama. As a doctor and Alabama's governor, the issue of human life, from conception to birth and beyond, is extremely important. I respect human life and do not want Alabama to be associated with an
organization that does not," Bentley said.

Alabama Medicaid Agency records show that
the state has paid Planned Parenthood
Southeast less than $5,000 over the last two
years. The payments were for contraceptives
for low-income women and not abortion.

Medicaid in this fiscal year paid the group
$3,417.58 for office visits, contraceptive implants and birth control shots. The state Medicaid Agency paid the group $933.79 in 2014 for an office visit, birth control shots and one IUD insertion and injections.

"We are disappointed that Gov. Bentley has
been distracted by a deceptive attack against
our organization instead of staying focused on
what really matters to women in Alabama. What Alabamians need is more access to health care, not less," said Staci Fox, president and CEO of Planned Parenthood Southeast.
Fox said the organization provides cancer
screenings, well-woman exams, birth control
options, and STD testing and treatment.
"Because of our health centers, low-income,
uninsured women and families were able to
access high-quality affordable health care through the safety net provided by Medicaid
funding," she said.

Planned Parenthood operates health care
clinics in Mobile and Birmingham.

The anti-abortion group, the Center for Medical Progress, released several secretly shot videos with Planned Parenthood executives describing how the organization provides fetal tissue to medical researchers and discussing different procedures and prices.

Planned Parenthood executives have denied
claims that the transactions were sales and said any donations are legal and ethical. The law allows abortion providers to be paid for
processing fees but not to profit from fetal tissue.


The U.S. Senate on Monday blocked Republican legislation to cut off federal funding to Planned Parenthood in the wake of the videos.

The Associated Press

Print this item

Star State Legislatures Call for Drug Law Fix
Posted by: IceWizard - 08-09-2015, 10:44 AM - Forum: Medical Marijuana - Replies (1)

By Steven Nelson
Aug. 6, 2015 | 5:28 p.m. EDT

National Conference of State Legislatures
members, meeting in Seattle this week, approved a call for congressional action on
marijuana reform. Washington state, along with
Colorado, has rolled out a regulated recreational marijuana market.

A nonpartisan national organization that
represents state legislatures demanded
Thursday that Congress overhaul federal drug
laws and allow states to establish their own
policies for marijuana and hemp.

The National Conference of State Legislatures
approved the policy statement in a voice vote
Thursday, throwing its support behind a states’
rights position that polls often find more popular than specific drug law reforms.

“The National Conference of State
Legislatures believes that federal laws, including the Controlled Substances Act, should be amended to explicitly allow states to set their own marijuana and hemp policies without federal interference and urges the administration not to undermine state marijuana and hemp policies,” the resolution says.

The resolution recognizes “members have
differing views on how to treat marijuana and
hemp in their states and believes that states
and localities should be able to set whatever
marijuana and hemp policies work best to
improve the public safety, health, and economic development of their communities.”

[READ: DEA Leader Now Certain: Heroin Obviously More Dangerous Than Pot]

State Rep. Renny Cushing, D-N.H., sponsored the measure. The lower house of New Hampshire’s legislature, in which he serves, last year became the first state legislative body in the U.S. to pass a tax-and-regulate marijuana legalization bill, though that effort later stalled.

Thus far, voter-passed initiatives have produced further-reaching effects than reforms approved by state legislatures, beginning with California’s groundbreaking medical marijuana initiative in 1996 and continuing with ballot initiatives that in 2012 and 2014 legalized recreational marijuana under local law in four states and the nation’s capital.
“The voters have stimulated conversation
among state legislators and state legislators in
response are calling on the federal government not to be an impediment," Cushing says. “[The resolution] means the states are no longer going to be willing participants in the war on drugs."

A super majority of 75 percent was required for adoption of the measure. Each state’s appointed representatives had one vote and 49 were on the floor, Cushing says, and opposition was so small there was no need for a recorded tally.

[ALSO: Missouri Man Serving Life for Pot Prepares for First Parole Hearing]

Though marijuana possession for any reason
outside limited research remains a federal crime, federal prosecutors and law enforcement agents generally respect state marijuana policies, in line with guidance from the Justice Department that encourages use of discretion focusing on certain priorities, such as preventing access to minors and interstate drug smuggling.


But there have been high-profile instances
where state autonomy has been seen as under assault. The Drug Enforcement Administration last year seized hemp seeds en route to Kentucky’s Department of Agriculture for legal pilot programs and in Washington state medical marijuana patients await sentencing after being convicted of violating federal law for tending a collective garden that only slightly exceeded state limits.

Congress reacted to these incidents last year by passing spending restrictions that bar the
Justice Department from using money to hinder state medical marijuana and hemp programs. The administration’s view of these restrictions, which did not change underlying federal law, is somewhat unclear. The House re-approved the amendments in June, but narrowly rejected a measure to protect state recreational marijuana laws.

“I think there’s every indication that a sea
change is taking place in the country,” Cushing
says. “People are realizing it’s the end of
prohibition, the parallels are very similar to what happened when the U.S. realized the prohibition of alcohol was a failed public policy.”

[MORE: Prosecutors Rally Against Sentencing Reform, Say Build More Prisons]

Cushing says he doesn’t know if any state
lawmakers have visited state-legal marijuana
shops in Seattle, where the conference was
hosted. “If I have time I may want to do that
myself,” he says, noting he did tour a bakery
making marijuana-infused goods.

Pro-legalization groups quickly issued
statements celebrating the action. “This resolution is a strong indication that legislators throughout the nation are not just hearing from but listening to their constituents,” said Karen O’Keefe, director of state policies for the Marijuana Policy Project, which intends to support a half dozen legalization ballot initiatives in 2016.

“The overwhelming support for this resolution
shows clear bipartisan support for states' right
to create their own drug policies,” said Diane
Goldstein of Law Enforcement Against
Prohibition.

Passage of the measure came hours before the first televised presidential debate in the 2016 Republican primary. Some candidates appearing on the debate stage, notably Gov. Chris Christie, R-N.J., have suggested they would fully enforce the Controlled Substances Act and cripple state- regulated marijuana markets.

Print this item